BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26197808)

  • 1. Bioinformatics methods in drug repurposing for Alzheimer's disease.
    Siavelis JC; Bourdakou MM; Athanasiadis EI; Spyrou GM; Nikita KS
    Brief Bioinform; 2016 Mar; 17(2):322-35. PubMed ID: 26197808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
    Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
    Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
    Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
    Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical genetics-based drug repurposing for Alzheimer's disease.
    Zhang XZ; Quan Y; Tang GY
    Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases.
    Emon MA; Kodamullil AT; Karki R; Younesi E; Hofmann-Apitius M
    J Alzheimers Dis; 2017; 56(2):677-686. PubMed ID: 28035920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network.
    Soleimani Zakeri NS; Pashazadeh S; MotieGhader H
    Biomed Res Int; 2021; 2021():1280237. PubMed ID: 34692825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer's disease through a systems biology approach and drug repurposing.
    Azizan Z; Zali H; Mirmotalebisohi SA; Bazrgar M; Ahmadiani A
    PLoS One; 2024; 19(5):e0304410. PubMed ID: 38809924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in drug repurposing using machine learning.
    Urbina F; Puhl AC; Ekins S
    Curr Opin Chem Biol; 2021 Dec; 65():74-84. PubMed ID: 34274565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
    Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
    J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell-led drug repurposing for Alzheimer's disease.
    Parolo S; Mariotti F; Bora P; Carboni L; Domenici E
    Sci Rep; 2023 Jan; 13(1):222. PubMed ID: 36604493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential hippocampal genes and pathways involved in Alzheimer's disease: a bioinformatic analysis.
    Zhang L; Guo XQ; Chu JF; Zhang X; Yan ZR; Li YZ
    Genet Mol Res; 2015 Jun; 14(2):7218-32. PubMed ID: 26125932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
    Maqbool M; Mobashir M; Hoda N
    Eur J Med Chem; 2016 Jan; 107():63-81. PubMed ID: 26562543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Computational Bipartite Graph-Based Drug Repurposing Method.
    Zheng S; Ma H; Wang J; Li J
    Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning identifies candidates for drug repurposing in Alzheimer's disease.
    Rodriguez S; Hug C; Todorov P; Moret N; Boswell SA; Evans K; Zhou G; Johnson NT; Hyman BT; Sorger PK; Albers MW; Sokolov A
    Nat Commun; 2021 Feb; 12(1):1033. PubMed ID: 33589615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
    PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Computational Network Biology Approach to Uncover Novel Genes Related to Alzheimer's Disease.
    Zanzoni A
    Methods Mol Biol; 2016; 1303():435-46. PubMed ID: 26235083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.
    Yang X; Huang WT; Wu HY; He RQ; Ma J; Liu AG; Chen G
    Oncol Rep; 2019 Apr; 41(4):2241-2253. PubMed ID: 30816547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
    Hashimoto M; Kazui H; Matsumoto K; Nakano Y; Yasuda M; Mori E
    Am J Psychiatry; 2005 Apr; 162(4):676-82. PubMed ID: 15800138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.